متابعة
Marco Siccardi
Marco Siccardi
بريد إلكتروني تم التحقق منه على liverpool.ac.uk
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations
S Rodríguez-Nóvoa, P Labarga, A D'avolio, P Barreiro, M Albalate, ...
Aids 24 (7), 1064-1066, 2010
1632010
Validation of a rapid and sensitive high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS) assay for the simultaneous determination of existing and new …
L Else, V Watson, J Tjia, A Hughes, M Siccardi, S Khoo, D Back
Journal of Chromatography B 878 (19), 1455-1465, 2010
1622010
HPLC–MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients
A D’Avolio, M Siccardi, M Sciandra, B Lorena, S Bonora, L Trentini, ...
Journal of Chromatography B 859 (2), 234-240, 2007
1432007
New HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma
S De Francia, A D’Avolio, F De Martino, E Pirro, L Baietto, M Siccardi, ...
Journal of Chromatography B 877 (18-19), 1721-1726, 2009
1332009
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 …
A D'Avolio, L Baietto, M Siccardi, M Sciandra, M Simiele, V Oddone, ...
Therapeutic Drug Monitoring 30 (6), 662-669, 2008
1322008
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing …
C Wyen, H Hendra, M Siccardi, M Platten, H Jaeger, T Harrer, S Esser, ...
Journal of antimicrobial chemotherapy 66 (9), 2092-2098, 2011
1292011
Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling
DM Moss, M Siccardi
British journal of pharmacology 171 (17), 3963-3979, 2014
1092014
Physiologically based pharmacokinetic modelling to inform development of intramuscular long-acting nanoformulations for HIV
RKR Rajoli, DJ Back, S Rannard, CL Freel Meyers, C Flexner, A Owen, ...
Clinical pharmacokinetics 54, 639-650, 2015
1072015
HPLC–MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions
A D’Avolio, M Simiele, M Siccardi, L Baietto, M Sciandra, S Bonora, ...
Journal of pharmaceutical and biomedical analysis 52 (5), 774-780, 2010
1062010
Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro–in vivo correlation
TO McDonald, M Giardiello, P Martin, M Siccardi, NJ Liptrott, D Smith, ...
Advanced healthcare materials 3 (3), 400-411, 2014
932014
Association of a Single-Nucleotide Polymorphism in the Pregnane X Receptor (PXR 63396C→T) with Reduced Concentrations of Unboosted Atazanavir
M Siccardi, A D'Avolio, L Baietto, S Gibbons, M Sciandra, D Colucci, ...
Clinical infectious diseases 47 (9), 1222-1225, 2008
932008
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma
L Baietto, A D’Avolio, FG De Rosa, S Garazzino, M Michelazzo, ...
Analytical and bioanalytical chemistry 396, 791-798, 2010
922010
Population pharmacokinetic modeling of the association between 63396C→ T pregnane X receptor polymorphism and unboosted atazanavir clearance
A Schipani, M Siccardi, A D'Avolio, L Baietto, M Simiele, S Bonora, ...
Antimicrobial agents and chemotherapy 54 (12), 5242-5250, 2010
902010
A HPLC–MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium …
A D’Avolio, M Simiele, M Siccardi, L Baietto, M Sciandra, V Oddone, ...
Journal of pharmaceutical and biomedical analysis 54 (4), 779-788, 2011
762011
Long-acting drugs and formulations for the treatment and prevention of HIV infection
C Flexner, A Owen, M Siccardi, S Swindells
International journal of antimicrobial agents 57 (1), 106220, 2021
742021
Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations
M Simiele, A D'Avolio, L Baietto, M Siccardi, M Sciandra, S Agati, J Cusato, ...
Antimicrobial agents and chemotherapy 55 (6), 2976-2978, 2011
732011
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals
A Schipani, C Wyen, T Mahungu, H Hendra, D Egan, M Siccardi, ...
Journal of antimicrobial chemotherapy 66 (6), 1332-1339, 2011
722011
Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir
DM Moss, WS Kwan, NJ Liptrott, DL Smith, M Siccardi, SH Khoo, DJ Back, ...
Antimicrobial agents and chemotherapy 55 (2), 879-887, 2011
712011
Divalent Metals and pH Alter Raltegravir Disposition In Vitro
DM Moss, M Siccardi, M Murphy, MM Piperakis, SH Khoo, DJ Back, ...
Antimicrobial agents and chemotherapy 56 (6), 3020-3026, 2012
662012
Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV
L Baietto, A D'Avolio, FG De Rosa, S Garazzino, S Patanella, M Siccardi, ...
Therapeutic drug monitoring 31 (1), 104-109, 2009
662009
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20